{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "G2019S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene cause late-onset PD. LRRK2 contains leucinerich repeats, a GTPase domain, a COR [C-terminal of Roc (Ras of complex)] domain, a kinase and a WD40 (Trp-Asp 40) motif.",
          "judgment": "Yes",
          "reasoning": "The text explicitly states that mutations in LRRK2 cause late-onset Parkinson's disease, and provides the genomic context of the gene."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Little is known about how LRRK2 is regulated, what its physiological substrates are or how mutations affect LRRK2 function. Thus far LRRK2 activity has only been assessed by autophosphorylation and phosphorylation of MBP (myelin basic protein), which is catalysed rather slowly . We undertook a KESTREL (kinase substrate tracking and elucidation) screen in rat brain extracts to identify proteins that were phosphorylated by an activated PD mutant of LRRK2 (G2019S) .",
          "judgment": "Yes",
          "reasoning": "The paper details a KESTREL screen, a well-established assay for identifying kinase substrates, making it applicable."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The study demonstrated that G2019S is a pathogenic variant, utilizing a KESTREL screen to identify moesin as a phosphorylated substrate, supporting the role of LRRK2 mutations in PD pathogenesis."
    }
  ]
}